MethodsAnimal treatment. Human recombinant HGF (hrHGF) was prepared as described elsewhere (14,20). Four-week-old male Sprague-Dawley rats housed in temperature-and light-controlled rooms were randomly assigned to four groups: (a) rats fed ethanol-containing liquid diets for 30 days (n = 4) (23) (Oriental Yeast. Co., Tokyo, Japan); (b) rats pair-fed isocaloric liquid diets without ethanol for 30 days (n = 4); (c) rats fed ethanolcontaining liquid diets for 37 days and then intravenously injected daily with saline during the last 7 days (n = 6); (d) rats fed ethanol-containing liquid diets for 37 days and given daily intravenous injections of 200 µg (n = 6) or 800 µg (n = 6) of hrHGF per kilogram of body weight during the last 7 days.The calorie distribution of liquid diets component is as follows: 16% as protein, 36% as fat, 13% as carbohydrate, and 35% as either ethanol or additional carbohydrate in the isocaloric liquid diets. The fatty acid composition of both ethanol-containing and isocaloric liquid diets consisted of 33.45% saturated fat, 66.26% unsaturated fat, and 0.29% unknown fat. Ethanol was incorporated into the liquid diets containing all required nutrients, and liquid diets were the only source of fluid and food provided, as A fatty liver is characterized by the hyperaccumulation of lipids within hepatocytes and is often caused by excessive alcohol intake. Rats fed ethanol-containing diets for 37 days showed remarkable increase in hepatic lipids and lipid droplet accumulation in the hepatocytes, indicating the onset of alcoholic fatty liver. Administration of hepatocyte growth factor (HGF) for the last seven days of ethanol treatment markedly decreased hepatic lipids to a level lower than that seen before HGF treatment. In contrast, serum levels of lipids and lipoproteins increased with HGF administration. Primary cultured hepatocytes prepared from the fatty liver retained lipid droplets during a 48-hour culture. However, when cultured in the presence of HGF, intracellular lipid concentrations decreased and lipid secretion was enhanced. Consistent with these events, HGF stimulated the rate of protein synthesis of apolipoprotein B (apoB) and enhanced subsequent mobilization of lipids into the medium. These results indicate that HGF administration induced recovery from the fatty liver, at least in part, by enhancing apoB synthesis and the subsequent mobilization of lipids from hepatocytes with fatty change. The possibility that HGF can be therapeutic for subjects with an alcohol-related fatty liver warrants further attention.